LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
29.73
+0.85 (2.94%)
May 2, 2025, 4:00 PM EDT - Market closed
LENZ Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
813.07M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | - | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | 15.00M | - | - |
Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLENZ News
- 2 days ago - LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025 - GlobeNewsWire
- 25 days ago - LENZ Therapeutics: Freedom From Reading Glasses - Seeking Alpha
- 5 weeks ago - LENZ Therapeutics Stock Is Attractive Before PDUFA - Seeking Alpha
- 6 weeks ago - LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 7 weeks ago - LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025 - GlobeNewsWire
- 2 months ago - LENZ Therapeutics to Host Commercial Day on April 15, 2025 - GlobeNewsWire
- 2 months ago - LENZ Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire